|
|
Volumn 57, Issue 5, 2006, Pages 1017-1019
|
|
Pilot study of continuous infusion cefepime in adult patients with cystic fibrosis [7]
a,b
a,b,c
|
|
Author keywords
lactams; Pharmacokinetics; Pseudomonas aeruginosa; t>MIC; Time above MIC
|
|
Indexed keywords
CEFEPIME;
INTERLEUKIN 8;
TOBRAMYCIN;
ADULT;
ANTIBACTERIAL ACTIVITY;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
BACTERIAL GROWTH;
BACTERIUM ISOLATE;
BACTERIUM ISOLATION;
BLOOD SAMPLING;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COMPARTMENT MODEL;
CONTINUOUS INFUSION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYSTIC FIBROSIS;
DISEASE EXACERBATION;
DRUG BLOOD LEVEL;
DRUG DOSE REDUCTION;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG INTERMITTENT THERAPY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEASIBILITY STUDY;
FOLLOW UP;
FORCED EXPIRATORY VOLUME;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
INFUSION PUMP;
INTERMETHOD COMPARISON;
LETTER;
LUNG FUNCTION TEST;
LUNG INFECTION;
MINIMUM INHIBITORY CONCENTRATION;
PILOT STUDY;
PROSPECTIVE STUDY;
PSEUDOMONAS AERUGINOSA;
SPUTUM ANALYSIS;
TREATMENT DURATION;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
ADULT;
ANTI-BACTERIAL AGENTS;
CEPHALOSPORINS;
CYSTIC FIBROSIS;
HUMANS;
INFUSIONS, INTRAVENOUS;
METABOLIC CLEARANCE RATE;
PILOT PROJECTS;
TIME FACTORS;
|
|
EID: 33645801392
PISSN: 03057453
EISSN: 14602091
Source Type: Journal
DOI: 10.1093/jac/dkl053 Document Type: Letter |
|
Times cited : (15)
|
|
References (5)
|
